Author Question: Organophosphates (used as pesticides and as biological weapons) are a. agonists that promote ACh ... (Read 180 times)

kaid0807

  • Hero Member
  • *****
  • Posts: 515
Organophosphates (used as pesticides and as biological weapons) are
 
  a. agonists that promote ACh production.
 b. antagonists that block ACh release.
 c. agonists that interfere with acetylcholinesteras e.
  d. antagonists that block ACh receptors.

Question 2

Sarin gas is a type of organophosphate. It was released in a Tokyo subway in 1995 by a religious sect, killing 12 people. Organophosphates are dangerous because they
 
  a. prevent the reuptake of acetylcholine (ACh), reducing the amount available for subsequent signaling.
  b. stimulate an larger than normal release of acetylcholine (ACh), leading to convulsions and death.
 c. interfere with acetylcholinesteras e (AChE), allowing acetylcholine (ACh) to overstimulate muscle fibers.
  d. occupy receptor sites for acetylcholine (ACh), preventing further signaling and paralyzing muscles.



Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

c

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library